Dengue fever is an infectious illness carried by mosquitoes and brought on by any of 4 associated dengue viruses. This illness was once referred to as “break-bone” fever as a result of it generally causes extreme joint and muscle ache that appears like bones are breaking. Well being consultants have identified about dengue fever for greater than 200 years.
Why Is the Examine of Dengue Fever a Precedence for NIAID?
Worldwide, about 50 million instances of dengue an infection happen annually, with 22,000 deaths, largely in kids. This contains 100 to 200 instances in the USA, largely in individuals who have just lately traveled overseas. Many extra instances seemingly go unreported as a result of some healthcare suppliers don’t acknowledge the illness. Within the Western hemisphere, the estimated financial burden of dengue is about $2.1 billion per 12 months.
How Is NIAID Addressing This Essential Matter?
Recognizing the risk to public well being posed by dengue, NIAID is funding practically 60 dengue analysis tasks, together with research on dengue hemorrhagic fever and dengue shock syndrome, probably the most extreme types of the illness. NIAID analysis priorities embrace efficient community-based prevention applications, improved laboratory-based worldwide surveillance, speedy diagnostic checks and therapies, and growth of and scientific trials for dengue vaccines.